Filing Details

Accession Number:
0000875320-11-000005
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-01-25 13:11:27
Reporting Period:
2011-01-21
Filing Date:
2011-01-25
Accepted Time:
2011-01-25 13:11:27
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
875320 Vertex Pharmaceuticals Inc / Ma VRTX Pharmaceutical Preparations (2834) 043039129
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1349077 Lisa Kelly C/O Vertex Pharmaceuticals Incorporated
130 Waverly Street
Cambridge MA 02139
Svp, Human Resources No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2011-01-21 1,709 $39.93 32,547 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,182 Indirect 401(k)
Footnotes
  1. Transaction made pursuant to Ms. Kelly-Croswell's company approved trading plan established under Rule 10b5-1.
  2. Open market sales reported on this line occurred at a weighted average price of $39.93 (range $39.81 to 40.02).
  3. Ms. Kelly-Croswell undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.